Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
08/2003
08/20/2003CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds
08/20/2003CN1437470A COX-2 inhibitors and the preventionof the side effects of radiation therapy
08/20/2003CN1436775A Process for preparing internal esters
08/20/2003CN1436766A Polyester compound for preparing olefine polymerizing catalyst
08/20/2003CN1118326C Preparation of phosphorus/vanadium maleic anhydride catalyst
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608214 Process for producing optically active γ-butyrolactone
08/19/2003US6608052 Compounds useful as anti-inflammatory agents
08/19/2003US6607778 Solid delivery systems for aroma ingredients
08/19/2003CA2133830C Micromechanical thermoelectric sensor element
08/19/2003CA2043733C Aromatic compounds
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066617A1 Process for producing lactone
08/14/2003WO2003066616A1 Method for the preparation of enterolactone from matairesinol
08/14/2003WO2003066583A1 Astaxanthin esters
08/14/2003WO2003066582A1 Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066556A1 Lignan derivatives
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003WO2003006446A8 Process for the production of ethers, typically thf
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153774 Process for the preparation of citalopram
08/14/2003US20030153736 Diagnosis and prognosis and radiotherapy of metastatic bone disease
08/14/2003US20030153603 Agent for enhancing accumulation of drugs in tumor tissues
08/14/2003US20030153602 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/14/2003US20030153599 Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003US20030153536 Compounds and methods of treating transplant rejection
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/13/2003EP1334970A1 Novel ft-0554a substances and process for the preparation thereof
08/13/2003EP1334961A1 Process for the preparation of glycine-N,N-diacetic acid derivatives
08/13/2003EP1334732A1 Pharmaceutical preparation containing copolyvidone
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1222166B1 Novel p-aminophenols and colorants containing said compounds
08/13/2003EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
08/13/2003EP0923568B9 Novel benzofuran-4-carboxamides
08/13/2003EP0915073B1 Process for producing optically active isomers of tricyclic compounds
08/13/2003EP0580692B1 Autoinducer
08/13/2003CN1436183A Process for preparation of saturated cyclic ethers
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives
08/12/2003US6605297 Accelerating uncoupled respiration and proton leak of the inner membrane of mitochondria which are induced by uncoupling proteins usingcoupled isomerized highly unsaturated fatty acids
08/12/2003CA2360303C Process for the preparation of pure citalopram
08/07/2003WO2003064617A2 Pestalotiopsis microsporia isolates and compounds derived therefrom
08/07/2003WO2003064406A1 Resistance-repellent retroviral protease inhibitors
08/07/2003WO2003064405A1 Drechslera anole derivatives, method for the production and use thereof
08/07/2003WO2003064404A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/07/2003WO2003064373A1 Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063849A1 Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2002051775A3 Methods for forming combinatorial libraries using reductive amination
08/07/2003US20030149303 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(S),4(S),5(S),7(S)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
08/07/2003US20030149299 Catalytic osmium-assisted oxidative cleavage of olefins
08/07/2003US20030149297 Hydrogenating in presence of rhodium/palladium catalyst, then dehydrating with acetic anhydride; for production of radiation transparent polyimides
08/07/2003US20030149294 Process for the preparation of latanoprost
08/07/2003US20030149283 Hydrogenation of tetrahydroxybutane to tetrahydrofuran
08/07/2003US20030149282 Process for producing a saturated cyclic ether
08/07/2003US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit
08/07/2003US20030149078 For therapy of cyclooxygenase-2 mediated disorders, cancer
08/07/2003US20030149052 Side effect reduction
08/07/2003US20030149023 Novel compounds with analgesic effect
08/07/2003US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/07/2003US20030148877 Metallocenes and catalysts for olefin-polymerisation
08/07/2003US20030147788 Conterflow reactor with a bundle of contact tubes
08/07/2003CA2474871A1 Furanone derivatives
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2473231A1 Resistance-repellent retroviral protease inhibitors
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1333020A2 "(PER)Haloethers"
08/06/2003EP1332140A1 Method for the production of menthalactone
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1049537B1 Catalytic compositions and methods for asymmetric allylic alkylation
08/06/2003EP0918747B1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
08/06/2003CN1434815A Method for the production of 2-coumarone and substituted 2-coumarones
08/06/2003CN1434796A Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
08/06/2003CN1434041A Anti-tumor medicine and use thereof
08/06/2003CN1434040A Medicine with 1,6-methylene-[10]-annulene difuran and steroid basic structure and use thereof
08/06/2003CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas
08/06/2003CN1117061C Process for preparation of cyclopropane carboxylic acids and intermediates therefor
08/06/2003CN1117055C Pesticide compounds, compositions and process for preparation thereof
08/05/2003US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
08/05/2003US6603042 Mixing acid halide and hydroxycarboxylic acid with maleic acid anhydride forming homogeneous solution having reduced tendency to discolor
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 472